戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tent changes in these pathways contribute to drug dependence.
2 peralgesia (increased pain sensitivity), and drug dependence.
3 and are being investigated as treatments for drug dependence.
4 itical role in aversion, negative-reward and drug dependence.
5 ess while 34% met the DSM-III-R criteria for drug dependence.
6 eing seen with bulimia and alcohol and other drug dependence.
7 le of antidepressant medications in treating drug dependence.
8 ting to impulsive and compulsive features of drug dependence.
9 ought to be responsible for the pathology of drug dependence.
10 ls drives ERK-JunB-p21 signalling to enforce drug dependence.
11 ferences in risk for relapse associated with drug dependence.
12 be critically involved in the development of drug dependence.
13 g disorders, obesity, as well as alcohol and drug dependence.
14 ntributes to the transition from drug use to drug dependence.
15 bolism in regions associated with reward and drug dependence.
16 rain abnormalities associated with stimulant drug dependence.
17 isocial behavior, and alcohol, nicotine, and drug dependence.
18 groups for genetic investigations of illicit drug dependence.
19  including extension of liability to illicit drug dependence.
20 edisposed individuals for the development of drug dependence.
21 disorders, including Parkinson's disease and drug dependence.
22 iability likely extends to nonopioid illicit drug dependence.
23 how genetic risk mediates the development of drug dependence.
24 f the central nervous system (CNS) including drug dependence.
25 y to several major psychiatric illnesses and drug dependence.
26 ion, a well-characterised model for onset of drug dependence.
27 sis for restricted behavioral repertoires in drug dependence.
28 ignals to reinforcement learning accounts of drug dependence.
29 cificity for the transmission of alcohol and drug dependence.
30  in neuropsychiatric disorders, obesity, and drug dependence.
31  therapeutic interventions aimed at treating drug dependence.
32  cue-induced cocaine craving associated with drug dependence.
33 or conduct disorder, alcohol dependence, and drug dependence.
34 to contribute to schizophrenic psychosis and drug dependence.
35 4% and 7.7%, respectively) exceeded rates of drug dependence (0.6% and 2.6%, respectively).
36 most common axis I disorders were alcohol or drug dependence (15 subjects), depression (11 subjects),
37  people, 14 938 (26%) had evidence of recent drug dependence, 50% (n = 7506) of whom were hospitalize
38                        Here we characterized drug dependence across a panel of over 75 MAPK-inhibitor
39  may modify the susceptibility to alcohol or drug dependence (AD or ND).
40 ith a 2- to 3-fold excess risk of developing drug dependence (adjusted relative risk = 2.6, 95% confi
41 stance use disorder, alcohol dependence, and drug dependence after stratifying probands by the presen
42 assified as having a nonalcohol, nonnicotine drug dependence alone.
43 2 newly incident clinical features of DSM-IV drug dependence), among subjects with no prior clinical
44 traumatic stress disorder (PTSD) with DSM-IV drug dependence and abuse are from cross-sectional studi
45                  We further review models of drug dependence and addiction and describe behavioral al
46 ewed with the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA).
47 d through the Semi-Structured Assessment for Drug Dependence and Alcoholism interview.
48 wed using the Semi-Structured Assessment for Drug Dependence and Alcoholism, a comprehensive psychiat
49 rol using the Semi-Structured Assessment for Drug Dependence and Alcoholism.
50 leus accumbens, which has been implicated in drug dependence and craving.
51 uring adolescence increases vulnerability to drug dependence and decreases the likelihood that indivi
52                  The familial aggregation of drug dependence and habitual smoking in siblings of alco
53          Because no ICD code for IDU exists, drug dependence and hepatitis C virus (HCV) have been us
54 or understanding individual vulnerability to drug dependence and novel treatments for the disorder.
55 oyed or underemployed have elevated rates of drug dependence and psychiatric comorbidities; consequen
56 t represents a candidate cognitive marker of drug dependence and treatment outcomes.
57                       Chronic opioid-induced drug dependence and withdrawal syndrome after opioid ces
58  area known to be involved in development of drug dependence and withdrawal.
59 rain stress systems that are dysregulated in drug dependence and withdrawal.
60 itical in developing interventions to combat drug dependence and withdrawal.
61 disorders, substance dependence (alcohol and drug dependence), and suicide attempts.
62 Making maladaptive choices is a component of drug dependence, and concurrent reinforcement schedules
63  mediates anxiety associated with stress and drug dependence, and it regulates ethanol intake.
64 les, smoking status, alcohol use, alcohol or drug dependence, and major depression.
65 or Asian race, geographic region, alcohol or drug dependence, and recent hospitalization with mental
66 mbers--and therefore likely to have predated drug dependence--and which aspects are specific to drug-
67 ependence; (2) DSM-IV drug abuse; (3) DSM-IV drug dependence; and (4) emerging dependence problems (1
68 regation of antisocial personality disorder, drug dependence, anxiety disorders, and mood disorders s
69   The three independent mutations conferring drug dependence are M1103T, T1208A, and V1210A.
70 erlying synaptic plasticity in this model of drug dependence are therefore fundamentally similar to t
71 ion, including those with evidence of recent drug dependence, are hospitalized while eligible for dir
72 rug dependence, the other primarily to licit drug dependence-are needed.
73                          This review selects drug dependence as a paradigmatic addiction, and further
74 on for 861 young adults (61% female) with no drug dependence at YAT0, low job control alone was assoc
75  clear evidence against the null hypothesis, drug dependence (beta = -0.27, P = 0.58) and long-term i
76 ive impairment, psychosis, recent alcohol or drug dependence, bipolar or severe personality disorder,
77                  Both alcohol dependence and drug dependence bred true in families without evidence f
78         Among persons with alcohol and other drug dependence, CCM compared with a primary care appoin
79 provide compelling evidence that alcohol and drug dependence, childhood conduct disorder, adult antis
80 bilized outpatients meeting DSM criteria for drug dependence (cocaine, heroin, or cannabis) and serio
81  3381], beta = 0.10 [95% CI, 0.06-0.14]) and drug dependence (concurrent [n = 749], beta = 0.19 [95%
82 uits involved in motivation that can lead to drug dependence, craving and relapse.
83 tionships between variation in CHRM2 and AD, drug dependence (DD) and affective disorders, using a no
84                                              Drug dependence (DD) is commonly co-morbid with alcohol
85 ying transitions from first drug use (DU) to drug dependence (DD) onset, we estimate a parsimonious s
86 e dependence [alcohol dependence (AD) and/or drug dependence (DD)] and 338 EA healthy controls.
87 for the Genetics and Treatment of Antisocial Drug Dependence, Denver and Boulder.
88 ic application in the management of obesity, drug dependence, depression, and other disorders.
89  larger number of substances and having more drug dependence diagnoses and symptoms.
90            Care for patients with alcohol or drug dependence diagnoses was more restricted than was c
91 orbidity (panic disorder, social phobia, and drug dependence), disability and restricted activity day
92 ed with HIV may also have psychiatric and/or drug dependence disorders.
93 ana, and more than 12% screened positive for drug dependence during the previous 12 months.
94                              For example, in drug dependence, dysfunctional value-based decision-maki
95     Among people who have evidence of recent drug dependence, frequent hospitalization-particularly m
96                                              Drug dependence generally has been treated as if it were
97 ated for alcoholism and/or other nonnicotine drug dependence had an increased cumulative mortality th
98                    Studies of remission from drug dependence have most often been based on treatment
99  and treat HIV, tuberculosis, hepatitis, and drug dependence have proven successful in prisons and ar
100 r of HIV-related symptoms, illicit drug use, drug dependence, heavy alcohol use, and being unemployed
101                A recent genome-wide study of drug dependence identified an association between cocain
102  predicted drug dependence in relatives, and drug dependence in comparison probands increased the ris
103                                              Drug dependence in probands increased the risk for drug
104 ependence in probands increased the risk for drug dependence in relatives irrespective of ADHD status
105   In addition, ADHD in the proband predicted drug dependence in relatives, and drug dependence in com
106 ction and personality traits associated with drug dependence in stimulant-dependent individuals (N=50
107 nimal data are available on the treatment of drug dependence in this patient population.
108 ently associated with screening positive for drug dependence included having many HIV-related symptom
109                     Craving is a hallmark of drug dependence, including dependence on nicotine.
110                                     Although drug dependence is common in patients with bipolar disor
111 uggest that the association between ADHD and drug dependence is most consistent with the hypothesis o
112 as helped shape the generally held view that drug dependence is primarily a social problem, not a hea
113 al predisposition in the human population to drug dependence is unknown.
114 delayed drug addition suggested (i) that the drug dependence lesion is at the stage of virus assembly
115 d late in growth cycles, suggesting that the drug-dependence lesion was at the step of virus assembly
116                                              Drug dependence may be at its core a pathology of choice
117 eir biological siblings without a history of drug dependence (N=50), and unrelated healthy volunteers
118 ndence (N=115 versus N=166, respectively) or drug dependence (N=78 versus N=203).
119 iral dynamics is modified to account for the drug dependence of intracellular delay and continuously
120 ty and amplified relaxation systolic load or drug dependence of ME-based indexes in failing versus co
121 , current clinical treatment for alcohol and drug dependence often excludes new pharmacotherapies app
122                               The effects of drug dependence on social systems has helped shape the g
123 antisocial behavior, alcohol dependence, and drug dependence) on childhood disruptive disorders (atte
124 role in the transition to and maintenance of drug dependence once initiated.
125 n, diabetes mellitus, obesity, dyslipidemia, drug dependence or tobacco use, and renal disease.
126 f endogenous endophthalmitis associated with drug dependence or use increased from 0.08 per 100 000 i
127 ies in patients with or without a history of drug dependence or use.
128 f these patients (n = 7783) had a history of drug dependence or use.
129 h intraocular inflammation in the setting of drug dependence or use.
130                                              Drug dependence produces significant and lasting changes
131 e in addiction while extending the idea that drug dependence represents a shift from initially recrea
132 e correlation between gradient variation and drug dependence severity in CUD.
133                                              Drug dependence should be insured, treated, and evaluate
134 nger age, being separated or divorced, other drug dependence, substance-induced psychiatric disorders
135 ation cohort), and self-reported alcohol and drug dependence symptoms at 18 and 24 years of age (CATS
136 ibution), expand the traditional concepts of drug dependence that emphasize limbic-regulated response
137  factors-one predisposing largely to illicit drug dependence, the other primarily to licit drug depen
138 ght to play a key role in the maintenance of drug dependence through negative reinforcement.
139 nse to treatments (adherence and relapse) of drug dependence vs type 2 diabetes mellitus, hypertensio
140 ons, neither parental alcohol dependence nor drug dependence was associated with a higher risk for be
141 Evidence for the heritability of alcohol and drug dependence was found.
142 sent in 20% of participants, mainly men, and drug dependence was present in 13%.
143 eas the association between dependent PD and drug dependence was significantly greater (P <.04) among
144 ng positive for any psychiatric disorder and drug dependence were examined in multivariate logistic r
145 neuropeptide Y, nociceptin [orphanin FQ]) in drug dependence, with emphasis on the neuropharmacologic
146 roduct (multiple PDZ domain protein) affects drug dependence, withdrawal and relapse.
147 involved in addiction that may contribute to drug dependence, withdrawal and related processes.
148 e, Z=5.36, p<0.001; 3.4% vs. 1.1% males with drug dependence, Z=3.70; p<0.001).

 
Page Top